S&P 500   4,467.71
DOW   35,123.36
QQQ   367.91
2 Tech Stocks to Buy and One to Avoid in August
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Stocks to Buy No Matter Which Way Inflation Moves
3 Stocks to Buy After Heavy Insider Buying
Biden To Unleash "Choke Point" Operation On America? (Ad)
2 Alternatives To Tesla (1 Safe, 1 More Risky)
The Rivian Market Is About To Shift Into A Higher Gear 
Biden To Unleash "Choke Point" Operation On America? (Ad)
7 Best Fintech ETFs to Buy Now
How major US stock indexes fared Wednesday, 8/9/2023
S&P 500   4,467.71
DOW   35,123.36
QQQ   367.91
2 Tech Stocks to Buy and One to Avoid in August
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Stocks to Buy No Matter Which Way Inflation Moves
3 Stocks to Buy After Heavy Insider Buying
Biden To Unleash "Choke Point" Operation On America? (Ad)
2 Alternatives To Tesla (1 Safe, 1 More Risky)
The Rivian Market Is About To Shift Into A Higher Gear 
Biden To Unleash "Choke Point" Operation On America? (Ad)
7 Best Fintech ETFs to Buy Now
How major US stock indexes fared Wednesday, 8/9/2023
S&P 500   4,467.71
DOW   35,123.36
QQQ   367.91
2 Tech Stocks to Buy and One to Avoid in August
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Stocks to Buy No Matter Which Way Inflation Moves
3 Stocks to Buy After Heavy Insider Buying
Biden To Unleash "Choke Point" Operation On America? (Ad)
2 Alternatives To Tesla (1 Safe, 1 More Risky)
The Rivian Market Is About To Shift Into A Higher Gear 
Biden To Unleash "Choke Point" Operation On America? (Ad)
7 Best Fintech ETFs to Buy Now
How major US stock indexes fared Wednesday, 8/9/2023
S&P 500   4,467.71
DOW   35,123.36
QQQ   367.91
2 Tech Stocks to Buy and One to Avoid in August
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Stocks to Buy No Matter Which Way Inflation Moves
3 Stocks to Buy After Heavy Insider Buying
Biden To Unleash "Choke Point" Operation On America? (Ad)
2 Alternatives To Tesla (1 Safe, 1 More Risky)
The Rivian Market Is About To Shift Into A Higher Gear 
Biden To Unleash "Choke Point" Operation On America? (Ad)
7 Best Fintech ETFs to Buy Now
How major US stock indexes fared Wednesday, 8/9/2023

AmerisourceBergen (ABC) Stock Forecast, Price & News

$185.72
+0.35 (+0.19%)
(As of 08/9/2023 ET)
Compare
Today's Range
$184.85
$186.85
50-Day Range
$172.60
$193.39
52-Week Range
$135.14
$194.79
Volume
3.87 million shs
Average Volume
1.40 million shs
Market Capitalization
$37.60 billion
P/E Ratio
22.62
Dividend Yield
1.04%
Price Target
$189.36

AmerisourceBergen MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.86 Rating Score
Upside/​Downside
2.0% Upside
$189.36 Price Target
Short Interest
Healthy
2.26% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.55
Upright™ Environmental Score
News Sentiment
0.58mentions of AmerisourceBergen in the last 14 days
Based on 23 Articles This Week
Insider Trading
Selling Shares
$361 M Sold Last Quarter
Proj. Earnings Growth
6.63%
From $11.92 to $12.71 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.74 out of 5 stars

Medical Sector

63rd out of 970 stocks

Drugs, Proprietaries, & Sundries Industry

1st out of 7 stocks


ABC stock logo

About AmerisourceBergen (NYSE:ABC) Stock

AmerisourceBergen Corporation sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturer. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segments also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

ABC Price History

ABC Stock News Headlines

[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
AmerisourceBergen Co. (ABC) To Go Ex-Dividend on August 10th
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
AmerisourceBergen (NYSE:ABC) Issues FY 2023 Earnings Guidance
AmerisourceBergen Corp. Q3 Profit Increases, beats estimates
AmerisourceBergen Raises FY23 Outlook
See More Headlines
Receive ABC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AmerisourceBergen and its competitors with MarketBeat's FREE daily newsletter.

ABC Company Calendar

Ex-Dividend for 5/30 Dividend
5/11/2023
Dividend Payable
5/30/2023
Last Earnings
8/02/2023
Today
8/09/2023
Ex-Dividend for 8/28 Dividend
8/10/2023
Dividend Payable
8/28/2023
Fiscal Year End
9/30/2023
Next Earnings (Estimated)
11/02/2023

Industry, Sector and Symbol

Industry
Drugs, proprietaries, & sundries
Sub-Industry
Health Care Distributors
Sector
Medical
CUSIP
03073E10
Employees
44,000
Year Founded
2001

Price Target and Rating

Average Stock Price Forecast
$189.36
High Stock Price Forecast
$215.00
Low Stock Price Forecast
$169.00
Forecasted Upside/Downside
+2.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
14 Analysts

Profitability

Net Income
$1.70 billion
Pretax Margin
0.82%

Debt

Sales & Book Value

Annual Sales
$254.43 billion
Cash Flow
$14.99 per share
Book Value
$4.55 per share

Miscellaneous

Free Float
161,770,000
Market Cap
$37.60 billion
Optionable
Optionable
Beta
0.56

Social Links

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Steven H. CollisMr. Steven H. Collis (Age 62)
    Chairman, Pres & CEO
    Comp: $5.49M
  • Mr. James F. Cleary Jr. (Age 60)
    Exec. VP & CFO
    Comp: $2.12M
  • Dr. Robert P. Mauch Ph.D. (Age 56)
    PharmD, Exec. VP & COO
    Comp: $2.32M
  • Ms. Gina K. ClarkMs. Gina K. Clark (Age 66)
    Exec. VP and Chief Communications & Admin. Officer
    Comp: $1.68M
  • Ms. Silvana BattagliaMs. Silvana Battaglia (Age 55)
    Exec. VP & Chief HR Officer
    Comp: $1.58M
  • Mr. Lazarus KrikorianMr. Lazarus Krikorian (Age 58)
    Sr. VP, Chief Accounting Officer & Corp. Controller
  • Bennett S. Murphy
    Sr. VP of Investor Relations
  • Ms. Kathy H. Gaddes (Age 60)
    Exec. VP & Chief Compliance Officer
  • Ms. Elizabeth S. CampbellMs. Elizabeth S. Campbell (Age 48)
    Exec. VP & Chief Legal Officer
  • Mr. John G. ChouMr. John G. Chou (Age 67)
    Exec. VP and Special Advisor to the Chairman & CEO













ABC Stock - Frequently Asked Questions

Should I buy or sell AmerisourceBergen stock right now?

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for AmerisourceBergen in the last year. There are currently 2 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ABC shares.
View ABC analyst ratings
or view top-rated stocks.

What is AmerisourceBergen's stock price forecast for 2023?

14 brokers have issued 12 month target prices for AmerisourceBergen's stock. Their ABC share price forecasts range from $169.00 to $215.00. On average, they predict the company's stock price to reach $189.36 in the next year. This suggests a possible upside of 2.0% from the stock's current price.
View analysts price targets for ABC
or view top-rated stocks among Wall Street analysts.

How have ABC shares performed in 2023?

AmerisourceBergen's stock was trading at $165.71 at the beginning of the year. Since then, ABC stock has increased by 12.1% and is now trading at $185.7250.
View the best growth stocks for 2023 here
.

Are investors shorting AmerisourceBergen?

AmerisourceBergen saw a decrease in short interest in the month of July. As of July 15th, there was short interest totaling 3,810,000 shares, a decrease of 8.4% from the June 30th total of 4,160,000 shares. Based on an average daily volume of 1,320,000 shares, the days-to-cover ratio is presently 2.9 days. Currently, 2.3% of the shares of the stock are short sold.
View AmerisourceBergen's Short Interest
.

When is AmerisourceBergen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our ABC earnings forecast
.

How were AmerisourceBergen's earnings last quarter?

AmerisourceBergen Co. (NYSE:ABC) issued its earnings results on Wednesday, August, 2nd. The company reported $2.92 EPS for the quarter, topping the consensus estimate of $2.83 by $0.09. The firm earned $66.95 billion during the quarter, compared to analyst estimates of $63.93 billion. AmerisourceBergen had a trailing twelve-month return on equity of 612.69% and a net margin of 0.66%. AmerisourceBergen's revenue for the quarter was up 11.5% compared to the same quarter last year. During the same period last year, the business posted $2.62 earnings per share.
Read the conference call transcript
.

How often does AmerisourceBergen pay dividends? What is the dividend yield for AmerisourceBergen?

AmerisourceBergen announced a quarterly dividend on Wednesday, August 2nd. Stockholders of record on Friday, August 11th will be given a dividend of $0.485 per share on Monday, August 28th. This represents a $1.94 dividend on an annualized basis and a yield of 1.04%. The ex-dividend date of this dividend is Thursday, August 10th.
Read our dividend analysis for ABC
.

Is AmerisourceBergen a good dividend stock?

AmerisourceBergen (NYSE:ABC) pays an annual dividend of $1.94 per share and currently has a dividend yield of 1.05%. The company has been increasing its dividend for 18 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 23.63%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ABC will have a dividend payout ratio of 15.26% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ABC.

What guidance has AmerisourceBergen issued on next quarter's earnings?

AmerisourceBergen updated its FY23 earnings guidance on Wednesday, August, 2nd. The company provided earnings per share (EPS) guidance of $11.85-11.95 for the period, compared to the consensus EPS estimate of $11.86. The company issued revenue guidance of ~$257.67 billion, compared to the consensus revenue estimate of $255.31 billion.

What is Steve Collis' approval rating as AmerisourceBergen's CEO?

447 employees have rated AmerisourceBergen Chief Executive Officer Steve Collis on Glassdoor.com. Steve Collis has an approval rating of 83% among the company's employees.

What other stocks do shareholders of AmerisourceBergen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AmerisourceBergen investors own include NVIDIA (NVDA), Intel (INTC), AbbVie (ABBV), Walt Disney (DIS), CVS Health (CVS), Johnson & Johnson (JNJ), AT&T (T), JPMorgan Chase & Co. (JPM), Home Depot (HD) and Pfizer (PFE).

What is AmerisourceBergen's stock symbol?

AmerisourceBergen trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABC."

Who are AmerisourceBergen's major shareholders?

AmerisourceBergen's stock is owned by a variety of retail and institutional investors. Top institutional investors include Coho Partners Ltd. (0.72%), Bank of New York Mellon Corp (0.68%), Dimensional Fund Advisors LP (0.61%), Fort Washington Investment Advisors Inc. OH (0.51%), California Public Employees Retirement System (0.35%) and Swiss National Bank (0.31%). Insiders that own company stock include Elizabeth S Campbell, Gina Clark, Henry Wadsworth Mcgee III, John G Chou, John G Chou, Lazarus Krikorian, Leslie E Donato, Robert P Mauch, Silvana Battaglia, Steven H Collis and Walgreens Boots Alliance, Inc.
View institutional ownership trends
.

How do I buy shares of AmerisourceBergen?

Shares of ABC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AmerisourceBergen's stock price today?

One share of ABC stock can currently be purchased for approximately $185.73.

How much money does AmerisourceBergen make?

AmerisourceBergen (NYSE:ABC) has a market capitalization of $37.60 billion and generates $254.43 billion in revenue each year. The company earns $1.70 billion in net income (profit) each year or $8.21 on an earnings per share basis.

How many employees does AmerisourceBergen have?

The company employs 44,000 workers across the globe.

Does AmerisourceBergen have any subsidiaries?
The following companies are subsidiares of AmerisourceBergen: AB Singapore Investments Pte Ltd, AB UK Holdings Ltd, ASD Specialty Healthcare LLC, Access M.D., Alliance Healthcare, Amerisource Receivables Financial Corporation, AmerisourceBergen Drug Corporation, AmerisourceBergen Global Holdings GmbH, AmerisourceBergen Global Manufacturer Services GmbH, AmerisourceBergen Group GmbH, AmerisourceBergen International Holdings Inc., AmerisourceBergen Luxembourg S.a.r.L., AmerisourceBergen Services Corporation, AmerisourceBergen Sourcing LLC, AmerisourceBergen Specialty Group LLC, Anderson Packaging, AutoMed Technologies, BPL Group LLC, BPLH Ireland Unlimited Company, Bellco Health, Brecon Pharmaceuticals, Bridge Medical Inc, CD Smith Healthcare, H. D. Smith, IgG America, International Physician Networks L.L.C., IntrinsiQ, Lash Group, MWI Veterinary Supply, Network for Medical Communications & Research, PMSI, PharMEDium Healthcare, Pharmacy Healthcare Solutions, Premier Source, St. Francis Group, Trent Drug, US Bioservices, Wight Nederland Holdco 2 BV, World Courier, World Courier Group S.à r.l., and Xcenda.
Read More
How can I contact AmerisourceBergen?

AmerisourceBergen's mailing address is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. The official website for the company is www.amerisourcebergen.com. The company can be reached via phone at (610) 727-7000, via email at investorrelations@amerisourcebergen.com, or via fax at 800-640-5221.

This page (NYSE:ABC) was last updated on 8/10/2023 by MarketBeat.com Staff

My Account -